Sana Biotechnology (SANA) Stock Insights
$814.26M
Market Cap
-3.07
P/E
—
Forward P/E
64
Score
SANA price $2.72 +0.09 +3.42%
Stocklytics score rationale: value 59, quality 32, growth 100.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug candidates includes SG295…
Insights · Dividends · Forecast · Financials · Learn
$814.26M
Market Cap
-3.07
P/E
—
Forward P/E
64
Score